Author Guidelines

Submission Guidelines

All manuscripts should be submitted at  https://jifnr.ifnr.org/index.php/ifnr/about/submissions

Types of Articles

  • Original Research Articles: Full-length papers presenting novel findings.
  •  Review Articles: Comprehensive overviews of specific topics.
  •  Case Reports: Detailed presentations of single or multiple cases.
  •  Clinical Trials: Reports on clinical trial outcomes
  •  Letters to the Editor: Brief, relevant, and impactful communications.

Manuscript Preparation

  1. General Requirements:
  • Manuscripts must be written in English.
  • Use Times New Roman, font size 12, double-spaced throughout.
  • Include page numbers in the bottom right corner.
  1. Title Page:
  • Title of the manuscript.
  • Full names, affiliations, and email addresses of all authors.
  • Corresponding author’s contact information.
  1. Abstract:
  • A concise summary of the study (250 words maximum).
  • Should include Background, Methods, Results, and Conclusion.
  • Keywords (up to 5).
  1. Main Text:
  • Introduction: Brief background, objectives, and aims of the study
  • Methods: Detailed description of the methodology used.
  • Results: Clear and concise presentation of findings.
  • Discussion: Interpretation and implications of results, limitations, and future directions.
  • Conclusion: Summary of key findings and their significance.
  1. References:
  • Follow the Vancouver referencing style.
  • Ensure all references are cited in the text and listed at the end.
  1. Figures and Tables:
  • Include as separate files.
  • Numbered consecutively and referred to in the text.
  • Provide captions for all figures and tables.

Ethical Considerations

  • Research must comply with the Declaration of Helsinki.
  • Studies involving humans require ethics committee/IRB approval.
  • Informed consent must be obtained for identifiable patient data.
  • Authors must disclose conflicts of interest and funding sources.
  • Patient confidentiality must be strictly maintained.

Authorship Criteria

  • Substantial contribution to study conception, design, analysis, or interpretation.
  • Drafting or critically revising the manuscript.
  • Final approval of the version to be published.
  • Agreement to be accountable for all aspects of the work
    (Follow ICMJE guidelines).

Review Process

Manuscripts will be peer-reviewed by experts in the field.

Authors will receive feedback and may be required to revise their manuscripts. The journal will follow the double anonymous peer review process whether the identities of both the author and the reviewer will not be known to each other.

Every manuscript will be reviewed by two independent peer reviewers with decisions to accept. major/minor revisions or rejecting the manuscript.

Copyright

Copyright will be retained by the author(s) with a non-exclusive licence to publish agreement assigned to Indian Federation of Neurorehabilitation.

Licence to Publish Agreement should be read and signed by all the authors; and a scanned copy of the same should be emailed to ifnr2012@gmail.com after the manuscript is accepted for publication.

Conflicts of Interest

This requires the declaration of all competing financial and non-financial interests. If there is no competing interests, please state "The authors declare that they have no competing interests”.

Availability of data and materials

All manuscripts must include a statement about the availability of data and materials. Data availability statements should include information on where to find data supporting the results reported in the article, such as hyperlinks to publicly archived datasets analyzed or generated during the study, if applicable. If the manuscript does not contain any data, please state 'Not applicable' in this section.

Acknowledgements

Please acknowledge anyone who contributed to the article but does not meet the criteria for authorship, including anyone who provided professional writing services or materials. Authors should obtain permission to acknowledge all those mentioned in the Acknowledgements section.
If there is no one to acknowledge, please write "Not applicable" in this section.

Funding Statement

  • Authors are required to disclose any sources of financing (institutional, private, and corporate financial assistance) for the research they submit.
  • This information should be included after the article under the heading 'Acknowledgement' and submitted at the time of submission in the form of the name of the funding organization(s) and the grant number. If no financing is available, use the following syntax: "This research received no specific grant from any funding agency in the public, private, or not-for-profit sectors.

Artificial Intelligence (AI)–Assisted Technology

At submission, the authors should disclose whether they used Artificial Intelligence (AI)– assisted technologies (such as Large Language Models [LLMs], chatbots, or image creators) in the production of submitted work. Authors who use such technology should describe, in both the cover letter and the submitted work in the appropriate section if applicable, how they used it. For example, if AI was used for writing assistance, describe this in the acknowledgment section If AI was used for data collection, analysis, or figure generation, authors should describe this use in the methods Chatbots (such as ChatGPT) should not be listed as authors because they cannot be responsible for the accuracy, integrity, and originality of the work, and these responsibilities are required for authorship Therefore, humans are responsible for any submitted material that included the use of AI-assisted technologies. Authors should carefully review and edit the result because AI can generate authoritative-sounding output that can be incorrect, incomplete, or biased. Authors should not list AI and AI-assisted technologies as an author or co-author, nor cite AI as an author. Authors should be able to assert that there is no plagiarism in their paper, including in text and images produced by the AI.

Informed consent statement

 Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication. Patient consent should be written and archived with the journal, the authors, or both, as dictated by local regulations or laws. The Journal of Indian Federation of Neurorehabilitation  requires that all authors obtain written patient consent and that this be archived by the author and available for inspection for a period of at least three years. A written statement should be included in the manuscript that attests that the authors have obtained and archived written patient consent. Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance, and editors should so note, that such alterations do not distort scientific meaning.

Source : https://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html

Human and Animal rights statement

Research that is performed on humans should follow international and national regulations in
accordance with the Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-ofhelsinki-ethical-principles-for-medical-research-involving-human-subjects/) or any other relevant set of ethical principles. With regard to the use of experimental animals, any research performed must follow internationally recognized guidelines on animal welfare, as well as local and national regulations, in accordance with the U.K. Animals (Scientific Procedures) Act and associated guidelines, the EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals. All animal studies should also comply with the ARRIVE guidelines (http://www.nc3rs.org.uk/arrive-guidelines) and the 2013 AVMA euthanasia guidelines. A statement must be included in the Materials and methods section of the manuscript, identifying the institutional and/or licensing committee that has approved the experiments undertaken. Signed proof of this approval from the committee must also be provided.

Clinical Trial Registration

As per ICMJE guidelines, some trials assign health care providers, rather than patients, to intervention and comparison/control groups. If the purpose of the trial is to examine the effect of the provider intervention on the health outcomes of the providers' patients, then investigators should register the trial. If the purpose is to examine the effect only on the providers (for example, provider knowledge or attitudes), then registration is not necessary.

If the manuscript submitted is based on a clinical trial as per the above ICMJE guidelines, Journal of Indian Federation of Neurorehabilitation   requires registration of clinical trials and the journal would only publish clinical trials that have been registered with a clinical trial registry that allows free online access to public.

Registration in the Clinical trial registry -India - https://ctri.nic.in/Clinicaltrials/login.php and providing the CTRI number along with the manuscript is mandatory.

The ICMJE accepts registration in the following registries also:

In addition to the above registries, starting in June 2007 the ICMJE will also accept registration in any of the primary registries that participate in the WHO International Clinical Trials Portal (see https://www.who.int/clinical-trials-registry-platform/network/primary-registries).

Authors are encouraged to use the relevant research reporting guidelines for the study type provided by the EQUATOR Network.

Reporting Guidelines

This will ensure that enough information is provided to  editors, peer reviewers and readers to understand how the research was performed and to judge whether the findings are likely to be reliable.

The key reporting guidelines are:

Case reports: CARE guidelines https://www.care-statement.org/

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Contact Information

For any queries, please contact the editorial office at: ifnr2012@gmail.com.